Select Agents
1.0 Policy
It is the policy of California State University, Fullerton
that all laboratories and campus facilities that will use,
transfer, possess, or receive select agents must comply with
Possession, Use, and Transfer of Select Agents and Toxins,
42 Code of Federal Regulations Part 73. http://www.cdc.gov/od/sap/42_cfr_73_final_rule.pdf
2.0 Scope
This policy applies to University faculty and staff, students
and visitors who receive, possess, use, transfer or acquire
Select Agent(s) while participating in any university and
non-university sponsored activity on all university facilities.
3.0 Definitions
3.1
"Select Agent" as defined by the CDC
and APHIS, means biological agents or toxins deemed a threat
to the public, animal or plant health, or to animal or plant
products.
3.2
"Biological agent" means any microorganism
(including, but not limited to bacteria, viruses, fungi,
rickettsiae, or protozoa), or infectious substance, or any
naturally occurring bioengineered or synthesized component
of any such microorganism or infectious substance, capable
of causing death, disease or other biological malfunction
in a human, an animal, a plant or another living organism;
deterioration of food, water, equipment, supplies or material
of any kind; or deleterious alteration of the environment.
3.3
"Toxin" means the toxic material or product
of plants, animals, microorganisms (including, but not limited
to bacteria, viruses, fungi, ricksettsiae or protozoa) or
infectious substances, or recombinant or synthesized molecule,
whatever their origin and method of production, and includes
any poisonous substance or biological product that may be
engineered as a result of biotechnology, produced by a living
organism; or any poisonous isomer or biological product,
homolog, or derivative of such a substance.
3.4
"Access" means having the permission
or ability to obtain or make use of Select Agents. Only
authorized persons are permitted access to Select Agents.
Access to a Select Agents can be limited by either security
containers or authorized personnel. For non-laboratory functions
including routine cleaning, maintenance and repairs, non-approved
individuals will be allowed access to areas where Select
Agents are accessible only if they are escorted and monitored
by authorized personnel.
3.5
"Authorized person" is an individual
who has been approved for access to Select Agents through
the successful completion of an FBI security risk assessment
as described in 42CFR73.8.
3.6
"Responsible Official" (RO) means the
individual designated by the entity to act on its behalf.
This individual must have the authority and control to ensure
compliance with the regulations. For purposes of this policy,
the RO is the Associate Vice President for Administration.
3.7
"Assistant Responsible Official" (ARO)
assists the RO in the implementation of the Select Agents
Program. For purposes of this policy, the ARO is the Radiation/Biosafety
Officer.
3.8
"Restricted Persons" are prohibited from
having access to Select Agents. A restricted person is any
individual who:
- has been convicted in any court of a crime punishable
by imprisonment for a term exceeding 1 year;
- is under indictment for a crime punishable by imprisonment
for a term exceeding 1 year
- is a fugitive from justice;
- is an unlawful user of any controlled substance (as
defined in section 102 of the Controlled Substances Act
(21 U.S.C. 802));
- is an alien illegally or unlawfully in the United States;
- has been adjudicated as a mental defective or has been
committed to any mental institution;
- is an alien (other than an alien lawfully admitted for
permanent residence) who is a national of Cuba, Iran,
Iraq, Libya, North Korea, Sudan or Syria, or any other
country to which the Secretary of State, pursuant to applicable
law, has made a determination (that remains in effect)
that such country has repeatedly provided support for
acts of international terrorism; or
- has been discharged from the Armed Services of the United
States under dishonorable conditions.
4.0 Implementation
The President approved this policy on XX, 2004, and authorized
its immediate university-wide application and distribution.
The Associate Vice President for Administration is responsible
for assuring the effective distribution of this Policy and
its annual review. Questions concerning this Policy and its
implementation should be directed to sfisher@fullerton.edu.
5.0 Accountability
5.1 Responsible Official (RO)
The Responsible Official (RO) is responsible for ensuring
that research involving the possession, use, transfer, or
receipt of select agents is conducted in accordance with
42 Code of Federal Regulations Part 73, also known as the
"Select Agent Rule." The Associate Vice President
for Administration will serve as the RO for the Campus.
Responsibilities include:
- Administration of the Select Agent Program and coordination
with CDC regarding the Select Agent Registration process.
- Maintaining an inventory of the principal investigators
that are using Select Agents.
- Notifying the CDC if a Select Agent is depleted or
destroyed.
- Verifying that the requestor is an employee has a current
registration, and has an appropriate laboratory or campus
facility for the research proposed.
5.2 Alternate Responsible Facility Official (ARO)
The Alternate Responsible Facility Official (ARO) is the
Radiation/Biosafety Officer in the Environmental Health
and Instructional Safety office. The ARO's duties
include, but are not limited to:
- Maintain an inventory of select agents. Review and
update annually.
- Review research proposals and laboratory protocols involving
the possession and use of select agents.
- Provide select agent specific training to procurement
officials and principal investigators, as necessary.
- Verify that a select agent has been depleted or destroyed.
- Document all select agent activity including inventory,
purchases, exchanges, use and disposal. Maintain records
in a secure location.
5.3 Principal Investigator
The Principal Investigator (PI) is responsible for compliance
with all of the policies, practices, and procedures set
forth by this program. This responsibility extends to all
aspects of the select agent program including authorization
of laboratory personnel, proposing safety practices and
equipment, controlling access, security, and transferring
or receiving select agents. The PI may not receive agents
until they are registered with this program and have received
approval from the RO, EHIS and the Federal Health and Human
Services Secretary. The PI requesting the use of Select
Agents must notify the RO prior to the start
of any research or classroom activity involving select agents.
All new faculty will be surveyed for their potential use
of select agents.
6.0 Program
Registration
All principal investigators must register with the Centers
for Disease Control prior to the receipt, use, or transfer
of select agents that are on the list in the attached Appendix.
PI's must comply with all of the requirements established
by the Centers for Disease Control as outlined in 42 CFR 73.
Contact the ARO (278-7233) prior to planning
any work with select agents.
Authorization/Approval
Any person wishing to begin a research project, teaching
activity, or other work involving select agents must receive
authorization by the RO and ARO before the work
begins. EHIS will coordinate all requests for authorization
of select agent work.
Practices and Procedures
Practices and procedures for safe use of select agents will
be based upon the conditions set forth in Reference A, CDC-NIH
"Biosafety in Microbiological and Biomedical Laboratories"
(Sections III through VII and Appendix I) but may be modified
by RO and ARO.
http://www.cdc.gov/od/ohs/biosfty/bmbl4/b4ai.htm
Any modification of containment will be based upon a risk assessment.
http://www.cdc.gov/od/ohs/biosfty/bmbl4/bmbl4s5.htm
Training
All personnel that purchase or approve the purchase of select
agents must have training on the procedures necessary for
the purchase of select agents. Principal investigators that
possess, use, transfer, or receive select agents must have
training regarding (1) the symptoms of exposure, (2) a post-exposure
management protocol, (3) spill cleanup and decontamination,
(4) proper use of engineering, administrative and work practice
controls, and (5) personal protective equipment, and security
requirements for select agent possession and use, (6) purchasing,
transfer, shipping, and receiving protocols.
Security
All laboratories and campus facilities that purchase, possess,
use, transfer, or receive select agents must comply with all
of the security requirements established by the Centers for
Disease Control and Prevention for the inventory and containment
of select agents. CDC minimum recommendations are listed in
the Biosafety in Microbiological and Biomedical Laboratories
(BMBL) Appendix F.
http://www.cdc.gov/od/ohs/biosfty/bmbl4/b4af.htm
Laboratory Inspections
Laboratories and campus facilities that purchase, possess,
use, transfer, or receive select agents must be inspected
quarterly by the ARO to ensure that all requirements are being
met. If a facility is found to be in non-compliance, the CDC
Select Agent Certificate of Registration may be revoked.
Engineering Controls
Engineering controls, such as fume hoods and biological
safety cabinets, must be used as the primary containment method
to limit personnel exposure to select agents. Engineering
controls must be: (1) inspected in order to ensure efficient
removal of hazards and (2) must have a visual indication of
airflow to ensure airflow has fallen below acceptable standards.
Notification of laboratory personnel must be made prior to
any maintenance that will impact the capture velocity of ventilation
systems. Local exhaust ventilation systems including laboratory-type
chemical fume hoods and biosafety cabinets must be certified
upon installation, after maintenance and annually thereafter.
Hood inspection is performed by EHIS and/or ARO.
Administrative Controls
All principal investigators that purchase possess, use,
transfer, or receive select agents must develop operating
procedures to ensure safe work practices are being consistently
used. EHIS and/or ARO will assist PI's in the development
of these procedures. PI's must review the procedures
annually, or as necessary, to reflect changes. Standard Laboratory
Practices for Guidelines for Work with Toxins of Biological
Origin are addressed in the BMBL Appendix I.
http://www.cdc.gov/od/ohs/biosfty/bmbl4/b4ai.htm
Personal protective equipment
Personal protective equipment appropriate to the select
agent or biological toxin must be used to protect personnel
from exposure. Personal protective equipment must be approved
by EHIS and appropriate protection for the select agent used.
When a Select Agent is Depleted or Destroyed
The RO or ARO must verify the depletion or destruction of
the select agent. It is good practice to have at least 2 people
witness and document the destruction of the select agent.
The RO must maintain the records of destruction for a minimum
of 5 years following the depletion or the destruction of the
select agent. If the PI no longer has select agents, the CDC
must be notified in writing by the RO to have the PI removed
from the registration. The CDC will send a letter to confirm
the change.
Shipping of Select Agents or Biological Toxins
All select agents and biological toxins must be shipped
in accordance with the International Air Transport Association
(IATA) requirements as an "Etiologic Agent with a Dangerous
Goods Manifest" and must meet other applicable regulatory
requirements and Select Agent specific hazard information.
The PI requiring shipment or receipt of Select Agents must
notify the RO/ARO prior to shipment of Select Agents.
Shipper responsibilities include:
- Shipper is required to notify CDC of any transportation
incident involving a select agent at the CDC Emergency Phone
Number (1-800-232-0124), 24 hours a day, 7 days a week.
- Packages containing select agents are required to be
packaged as "Infectious Substances," and labeled
with "Infectious Substance and Etiologic Agent"
Label.
- Packaging requirements for select agents require that
the shipper's name and phone number appear on the
outer package, in order to be used in emergencies.
- The phone number must be answered 24 hours a day by the
shipper in case of emergency.
- Importers of select agents are also subject to CDC's
regulation 42 CFR Part 71.54, ("Importation of Etiologic
Agents and Vectors"), and are responsible for obtaining
an import permit from the CDC prior to importing Select
Agents.
- For questions regarding shipping or permitting issues
please contact the ARO at 714-278-7233.
Receipt of Select Agents or Biological Toxins
All select agents and biological toxins must be addressed
to and received by the Environmental Health and Instructional
Safety Office prior to delivery to the laboratories. Packages
will be picked up by EHIS personnel and processed in an appropriate
facility on campus. This is to ensure proper shipment, notification,
and tracking of select agents. The PI receiving select agents
must notify the RO/ARO prior to the shipment of select agents.
Appendix
Select Agents - HHS Select Agent Program
Viruses
- Crimean-Congo hemorrhagic fever virus
- Ebola viruses
- Lassa fever virus
- Marburg virus
- South American Hemorrhagic fever viruses (Junin, Machupo,
Sabia, Flexal, Guanarito)
- Tick-borne encephalitis complex viruses
- Variola major virus (Smallpox virus)
- Viruses causing Hantavirus pulmonary syndrome
- Yellow fever virus
Bacteria
Rickettsiae
- Rickettsia prowazekii
- Rickettsia rickettsii
Toxins
- Abrin
- Conotoxins
- Diacetoxyscirpenol
- Ricin
- Saxitoxin
- Tetrodotoxin
Bacteria
- Bacillus anthracis
- Brucella abortus
- Brucella melitensis
- Brucella suis
- Burkholderia (Pseudomonas) mallei
- Burkholderia (Pseudomonas) pseudomallei
- Clostridium botulinum
- Francisella tularensis
Fungi
Rickettsiae
Viruses
- Eastern Equine Encephalitis virus
- Equine Morbillivirus (Hendra virus) NIPAH virus
- Rift Valley fever virus
- Venezuelan Equine Encephalitis virus
Toxins
- Aflatoxins
- Botulinum toxins
- Clostridium perfringens epsilon toxin
- Shigatoxin
- Staphylococcal enterotoxins
- T-2 toxin
USDA High Consequence of Livestock Pathogens and Toxins
- African horse sickness virus
- African swine fever
- Akabane virus
- Avian influenza (highly pathogenic)
- Blue tongue virus (exotic)
- Bovine spongiform encepalopathy agent
- Camel pox virus
- Classical swine fever
- Cowdria ruminantium (heartwater)
- Foot and mouth disease virus
- Goat pox virus
- Japanese encephalitis virus
- Lumpy skin disease virus
- Malignant catarrhal fever
- Menangle virus
- Mycoplasma capricolum/M.F 38/M.M ycoides capri (contagious
caprine pleuropneumonia agent)
- Mycoplasma mycoides mycoides (contagious bovine pleuropneumonia
agent)
- Newcastle disease virus (exotic)
- Peste des petits ruminants
- Rinderpest virus
- Sheep pox
- Swine vesicular disease virus
- Vesicular stomatitis virus
EHIS-2/4/2004 approved 9/10/2004